SCHEMBL3579515

SCHEMBL3579515

O=C(Nc1ccc(F)c(C(F)(F)F)c1)Nc1ccc(-c2ccc(Cl)cc2)cc1-c1nnn[nH]1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 11/20 0.47
FLT3 P36888 3/20 0.45
CSF1R P07333 2/20 0.45
FLT1 P17948 2/20 0.45
FLT4 P35916 2/20 0.45
RET P07949 1/20 0.45
FGFR1 P11362 1/20 0.45
FRK P42685 1/20 0.45
CAMK2B Q13554 1/20 0.45
CAMK2D Q13557 1/20 0.45
NTRK3 Q16288 1/20 0.45
HIPK4 Q8NE63 1/20 0.45
AURKB Q96GD4 1/20 0.45
BLM P54132 1/20 0.43
WRN Q14191 1/20 0.43
RAF1 P04049 1/20 0.43
RIPK1 Q13546 2/20 0.43
KIT P10721 2/20 0.42
CNR1 P21554 2/20 0.41
BRAF P15056 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3581862 0.94 KDR (0.48) KDRFLT3CSF1RFLT1FLT4
SCHEMBL3584463 0.93 KDR (0.47) KDRFLT3CSF1RFLT1FLT4
SCHEMBL3577666 0.93 KDR (0.52) KDRBLMRAF1RIPK1BRAF
SCHEMBL3586253 0.88 KDR (0.47) KDRFLT3CSF1RFLT1FLT4
SCHEMBL3572047 0.88 KDR (0.51) KDRBLMRAF1RIPK1BRAF
SCHEMBL3576165 0.88 GRIK1 (0.48) KDRFLT3CSF1RFLT1FLT4
SCHEMBL5469601 0.88 KDR (0.46) KDRFLT3CSF1RFLT1FLT4
SCHEMBL3581507 0.86 KDR (0.51) KDRBLMRAF1RIPK1BRAF
SCHEMBL3574142 0.86 PSEN1 (0.44) KDRFLT3CSF1RFLT1FLT4
SCHEMBL3580593 0.86 GRIK1 (0.48) KDRFLT3CSF1RFLT1FLT4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070293553-A1 Diphenylurea Derivatives Useful As Potassium Channel Activators NEUROSEARCH A/S (DK) 2007-12-20 US claimed
US-20060178413-A1 Diphenylurea derivatives and their use as chloride channel blockers NEUSEARCH A/S (DK) 2006-08-10 US claimed
US-7691891-B2 Diphenylurea derivatives and their use as chloride channel blockers NEUROSEARCH A/S (DK) 2010-04-06 US disclosed
US-20070293553-A1 Diphenylurea Derivatives Useful As Potassium Channel Activators NEUROSEARCH A/S (DK) 2007-12-20 US disclosed
US-20060178413-A1 Diphenylurea derivatives and their use as chloride channel blockers NEUSEARCH A/S (DK) 2006-08-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070293553-A1 Diphenylurea Derivatives Useful As Potassium Channel Activators KCNJ2, KCNH2, KCNH3 KDR 1142/4885FLT3 2643/4885CSF1R 4006/4885
US-20060178413-A1 Diphenylurea derivatives and their use as chloride channel blockers CLIC1, CLIC4, CLCN2 KDR 2480/4885FLT3 3392/4885CSF1R 4779/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.